Compounds for treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9447049
APP PUB NO 20130197049A1
SERIAL NO

13676650

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GTX, INC.;UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ahn, Sunjoo Memphis, US 24 375
Chen, Jianjuan Memphis, US 1 28
Dalton, James Lakeland, US 38 714
Li, Wei Germantown, US 2284 14552
Miller, Duane D Germantown, US 179 4313
Wang, Jin Memphis, US 805 11628
Xiao, Min Memphis, US 65 498

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 20, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00